MINNEAPOLIS, March 02, 2023 (GLOBE NEWSWIRE) -- Jamf (NASDAQ: JAMF), the standard in managing and securing Apple at work, announced today that members of its management team will present at the following investor conference: The JMP Securities Technology …
REDWOOD CITY, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that …
CHARLOTTE, N.C., March 02, 2023 (GLOBE NEWSWIRE) -- LPL Financial LLC announced today that attorneys Mona Nadim and Rochelle Mayfield have been selected as 2023 Fellows for the Leadership Council on Legal Diversity (LCLD). This is the eighth year that LPL …
Company Achieves Highest Fiscal Year Revenue in Company History Strong Adoption of New Higher Margin Smoothie Carton Format Following Roll Out in Fourth Quarter of 2022 Full Year 2022 Revenue Increased 37% Year-Over-Year to Record $9.2 Million and Gross …
RESEARCH TRIANGLE PARK, N.C., March 02, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery …
MOUNTAIN VIEW, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today reported financial results for the fourth quarter …
Board of Directors Declared Total Dividends of $0.66 per Share for First Quarter 2023 Base Dividend Increased to $0.41 Per Share, Reflecting Improved Earnings Power of Fidus' Portfolio EVANSTON, Ill., March 02, 2023 (GLOBE NEWSWIRE) -- Fidus Investment …
MINNEAPOLIS, March 02, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the …
Second Quarter Highlights Revenue grows 52% year-over-year to $387.6 million Calculated billings grows 34% year-over-year to $493.8 million Deferred revenue grows 46% year-over-year to $1,111.9 million GAAP net loss of $57.5 million compared to GAAP net …
Initial clinical data from XTX101, XTX202 and XTX301 clinical trials anticipated in 2023 XTX202, a tumor-activated IL-2, demonstrated preliminary clinical pharmacodynamic evidence of tumor-selective activation, providing initial clinical platform …
SHANGHAI, China and NEW YORK, March 02, 2023 (GLOBE NEWSWIRE) -- TH International Limited (Nasdaq: THCH), the exclusive operator of Tim Hortons coffee shops in China (“Tims China” or the “Company”) today announced that it will participate in three investor …
- Approximately $71 Million of International Product Sales in 2022 - - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK, March 02, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical …
NEW YORK, March 02, 2023 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for February 2023 on its investor relations website. A data sheet showing this information can be found at: http://ir.nasdaq.com/financials/volume-statistics. …
PHOENIX, March 02, 2023 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, has been invited to present at the 35th Annual ROTH Conference being held at The Ritz Carlton, Laguna Niguel in Dana …
NEW YORK, March 02, 2023 (GLOBE NEWSWIRE) -- Taboola (Nasdaq: TBLA), a global leader in powering recommendations for the open web, helping people discover things they may like, today announced that members of its management team will present and host one- …
Clinical data updates expected in 2023 for all three programs NC525 (LAIR-1 mAb) dosed first patient in a Phase 1 trial in acute myeloid leukemia (AML) Ended 2022 with approximately $160 million in cash that is expected to fund operations into mid-2025 …
REDWOOD CITY, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the fourth quarter and full year ended December 31, …
Completes enrollment in Phase 2a DUET clinical trial of TERN-501 (THR-β agonist) as a treatment for NASH with top-line results expected in third quarter of 2023 On track to initiate U.S. clinical trial for TERN-701 (allosteric BCR-ABL inhibitor) in CML in …
Kemper Corporation KMPR announced today that Joseph P. Lacher, Jr., president, chief executive officer and chairman, and James J. McKinney, executive vice president and chief financial officer, will participate in an in-person fireside chat at the Raymond …
The Class: Robbins LLP informs investors that a shareholder filed a class action on behalf of all purchasers of Cognyte Software Ltd. CGNT securities between August 30, 2021 and October 31, 2022, for violations of the Securities Exchange Act of 1934. …
